-
1
The interpretation of Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update
Published 2024-09-01Subjects: “…|breast cancer|bone-modifying agent(bma)|bisphosphonates(bp)|adjuvant treatment…”
Get full text
Article -
2